Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- CheckyesterdayChange DetectedThe study details page now signals that recruitment is closed, and new help/navigation sections were added or revised (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading; a new revision version (v3.6.0) is shown.SummaryDifference0.1%

- Check8 days agoChange DetectedThe revision label on the page footer updated from v3.5.4 to v3.5.5, indicating a deployment update; it represents a backend update with no visible edits to study information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This signals an updated version of the page content for the study record.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s footer was updated to reflect a new ClinicalTrials.gov interface/revision version (v3.5.3 instead of v3.5.2). This is a platform/version display change rather than a change to the trial information.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Temuco (Araucania) and Viña del Mar (Valparaiso) as Chilean sites and removed the 'Región de' prefixes to standardize regional names.SummaryDifference0.3%

- Check87 days agoChange DetectedLocation entry changed from Napoli, Italy, 80131 to Naples, Italy, 80131, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.